Clinical Trial Update: Phase 3 Clinical Trial: D-methionine to Reduce Noise-Induced Hearing Loss (NIHL) [Phase 3]

View source ↗

Summary

Phase 3 trial of D-methionine to reduce noise-induced hearing loss was terminated; results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Noise-induced Hearing Loss

Drugs mentioned

• D-methionine (D-methionine)

Snippet

Sponsor: Southern Illinois University | Conditions: Noise-induced Hearing Loss | Phase 3 | Status: TERMINATED | Results posted: 2022-06-28